MANILA, Philippines – Sen. Panfilo Lacson on Saturday warned that senators, along with members of the House of Representatives, may be complicit in the ongoing controversy involving anomalous and ghost flood control projects, reiterating his call for complete transparency in the national budgeting process.

Lacson said on radio that lawmakers from both chambers routinely propose budget amendments or "insertions"—a practice that, while technically legal, can be exploited to channel funds into questionable infrastructure projects.
Lacson: Senators not exempt from scrutiny in ghost flood control project scandal
“I’m not saying it’s only House members,” Lacson said in Filipino. “It’s possible that some senators have inserted funding for such projects and even profited from the 25 percent share typically given to the ‘funder’ or proponent.”
Pressed further on whether senators might be tied to these fraudulent schemes, the senator replied, “There may be senators and House members who are connected to anomalous flood control projects.”
Lacson: Senators not exempt from scrutiny in ghost flood control project scandal, This news data comes from:http://www.gangzhifhm.com
Lacson, a long-time advocate for budget transparency, refrained from naming specific individuals, stressing the importance of solid evidence. “It’s not right to name names without proof,” he said. “In my case, I only make findings public once they are backed by factual and verifiable information.”
- Protesters storm Discaya compound for second straight day
- US warship heading toward Caribbean Sea
- Lawmaker linked to anomalous flood control projects in US for medical reasons, says House spokesman
- Trump health misinformation swirls despite denial
- CFO office moves from Quezon City to Pasay
- Housing secretary declares 'zero-tolerance' policy on corruption
- MMDA inks deal with DBM for G-3 program
- Cyclone's trough, habagat will bring cloudy skies, rain showers over PH
- China races to build world’s largest solar farm
- Trump plans a hefty tax on imported drugs, risking higher prices and shortages